RP
DGX icon

Richard Pzena’s Quest Diagnostics DGX Stock Holding History

Richard Pzena’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,966
Closed -$241K – 183
2022
Q3 		$241K Hold
1,966
– – ﹤0.01% 168
2022
Q2 		$261K Hold
1,966
– – ﹤0.01% 159
2022
Q1 		$269K Buy
+1,966
New +$274K ﹤0.01% 169
2014
Q4 		– Sell
-429,700
Closed -$26.1M – 142
2014
Q3 		$26.1M Sell
429,700
-1,400
-0.3% -$86.3K 0.14% 101
2014
Q2 		$25.3M Sell
431,100
-541,100
-56% -$31.7M 0.14% 102
2014
Q1 		$56.3M Sell
972,200
-242,850
-20% -$13M 0.32% 59
2013
Q4 		$65.1M Buy
1,215,050
+544,400
+81% +$32.3M 0.38% 55
2013
Q3 		$41.4M Buy
670,650
+5,275
+0.8% +$316K 0.27% 69
2013
Q2 		$40.3M Buy
+665,375
New +$39.6M 0.27% 66

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Richard Pzena's DGX Position: Q4 2022 in Review

Richard Pzena sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 1,966 shares — an estimated $241K sold.

Richard Pzena first reported a position in DGX in Q2 2013 and held it in 9 quarters. The position peaked at $65.1M in Q4 2013. 880 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Richard Pzena reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Richard Pzena sold 1,966 Quest Diagnostics shares in Q4 2022, an estimated $241K.
  • Richard Pzena first reported a position in Quest Diagnostics in Q2 2013 and held it in 9 quarters.
  • Richard Pzena's Quest Diagnostics position peaked at $65.1M in Q4 2013.
  • 880 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Pzena Investment Management's 13F filing for Q4 2022, filed 3 Feb 2023.